Visura Technologies announced today that Christine Horton has assumed the role of president and CEO at the medical device company.
Minneapolis-based Visura develops state-of-the-art visualization solutions for improving the quality and efficiency of transesophageal echocardiogram (TEE) probe intubation.
The company said in a news release that Horton takes on the leadership position as Visura prepares for the U.S. commercialization efforts for its TEECAD system. Visura designed the FDA-cleared TEECAD system as a disposable camera that connects to TEE probes to offer physicians real-time visualization during esophageal intubation, improving probe placement for TEE procedures.
Horton holds 30 years of commercialization experience, having led startups and mid-sized companies, with her past roles including CEO at CoreSpine, where she raised capital, published data and led the company through FDA clearance.
“This is a pivotal t…